First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready? - Test2 - elhamkhani - TriplyDB

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

http://www.wikidata.org/entity/Q47283164

about

New therapeutic options opened by the molecular classification of gastric cancer.

P2860

Q55527185-A88FE346-4A0E-4982-907A-93848224E7E6

P2860

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

http://www.wikidata.org/entity/Q47283164

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

@en

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

@nl

type

label

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

@en

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

@nl

prefLabel

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

@en

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

@nl

P1433

Q47283164-8172043E-4114-49A6-84B7-D2ADCFC48347

P1476

Q47283164-2878A032-6C2C-4493-A23E-68DDB775702E

P2093

Q47283164-FA2AF5A2-6D7B-4E63-8CA9-26616DF4E378

P2860

Q47283164-00032EB9-CEC8-4B9A-9187-D0A264A22C93

Q47283164-06068003-E7FF-4F2D-A274-8DEF9EEB54EA

Q47283164-12022995-E347-4643-9E02-CBF4BA15CAC6

Q47283164-129FEE30-CAB4-4DFE-A056-87138CC18C96

Q47283164-17E553AE-9C70-4954-ACF1-EB46E12812CC

Q47283164-18E07B99-3E51-49B4-BE1F-F1533F2A0B6D

Q47283164-19F71EAE-447B-43CE-8A12-221BECD60760

Q47283164-1F2BEF2D-E68C-4039-91C7-01C82F3B117B

Q47283164-2FD3CA5D-FE8C-450D-BDD5-5E17CA235116

Q47283164-34984959-8B79-44EC-B510-B1E723A71A0F

P304

Q47283164-DB58337F-15D3-41D6-82DB-9F96DC7A5CDC

P31

Q47283164-5766AC35-E6E9-49E2-9625-D276B60C1B74

P356

Q47283164-34C5576C-9FF8-4919-A066-E4C7AA8100D3

P407

Q47283164-3E62C8AB-EC0F-4310-BB23-C62524B90011

P433

Q47283164-75232E36-9106-4A6A-B8E9-3808D6320063

P478

Q47283164-ACD64445-CDBF-419B-9B6E-A398769F4BE5

P50

Q47283164-30416541-FBC0-490F-ABB4-1C3EE0CD795D

P577

Q47283164-75D66B09-7723-4CCA-8FC7-F50666D661DE

P698

Q47283164-60FBCD8B-1026-482C-9493-3FBDF01617C6

P921

Q47283164-31876FBF-538B-496B-9A0A-8FD683A0365C

Q47283164-B38C76EF-49E8-4021-8FAF-62B48142C149

P932

Q47283164-D25BC609-F1E3-4CD7-826F-96A483F66619

P356

1566523217666171121165935

P1433

Current Gene Therapy

P1476

First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

@en

P2093

Marcus McLeod

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular profiling of patient-derived breast cancer xenografts

Drug development: Raise standards for preclinical cancer research

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

Systemic Immunotherapy for the Treatment of Brain Metastases

Immune Checkpoint Blockade in Cancer Therapy

Lost in translation: animal models and clinical trials in cancer treatment

The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it?

Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

Genome remodelling in a basal-like breast cancer metastasis and xenograft

P304

309-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1566523217666171121165935

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Francoise E. Baylis

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29173170

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

5769084

http://www.w3.org/2001/XMLSchema#string